Friday, July 24, 2015

FDA Approves Cholesterol Drug From Regeneron, Sanofi

Federal regulators approved the first of a new class of cholesterol-lowering medicines, developed by Regeneron and Sanofi. The drug, called Praluent, provides a new option for high-risk heart patients.

from WSJ.com: US Business http://ift.tt/1OCNGh8
via IFTTT

No comments:

Post a Comment